Eureka 93 Inc. (Eureka93) is an integrated life sciences company focused on the cultivation, extraction, and distribution of cannabis and hemp-derived cannabidiol (CBD) through it’s Health Canada licensed Artiva facility in Ottawa, Canada. For more information, please visit: Eureka93.com
SoftLab9 Software Solutions Inc. is an incubator specializing in developing, launching, acquiring and vertically integrating companies. They foster a portfolio of assets internally while providing engineering, capital, executive management and Silicon Valley introductions. SOFT brings together innovative ideas based on solid foundations and experienced teams to build leading mobile companies with incredible user experiences.
The Exchange has determined that FogChain Corp. (the “Issuer”) has not met the continued listing requirements as set out in CSE Policy 2, Appendix A section 2.9.
Pursuant to Policy 6 section 2.4, the Issuer may not rely on confidential price protection, nor may the Issuer complete any financing without prior Exchange approval.
In accordance with Policy 3, section 5.1, the .X extension is added to the listed securities of Issuers that the Exchange has deemed to be inactive.
Spey Resources Corp. («Spey») est une société d’exploration minière junior. Spey se consacre à l’acquisition, à l’exploration et à l’évaluation des propriétés des ressources naturelles.
Spey Resources Corp. (“Spey”) is a junior mineral exploration company. Spey is engaged in the business of acquiring, exploring and evaluating natural resource properties.
Spey has an option to acquire a 100% undivided interest in the Silver Basin Property (the “Property”) located in the Revelstoke Mining Division, of southern British Columbia.
SOL Global is an international investment company with a focus on, but not limited to, cannabis and cannabis related companies in legal U.S. states, the hemp and CBD marketplaces and the emerging European cannabis and hemp marketplaces. Its strategic investments and partnerships across cultivation, distribution and retail complement the company’s R&D program with the University of Miami. It is this comprehensive approach that is positioning SOL Global as a future front runner in the United States’ medical cannabis industry.